505308 | CDDO-Me - CAS 218600-53-4 - Calbiochem

CDDO-Me - CAS 218600-53-4 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: NSC 713200, Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate, Bardoxolone methyl, BARD, Nrf Activator V

505308
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₃₂H₄₃NO₄ 218600-53-4

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      5.05308.0001
      Retrieving availability...
      —
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          		Glass bottle 10 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          —
          Request Pricing
          		 —
          Description
          OverviewA cell-permeable, bioavailable synthetic oleanane triterpenoid compound with anti-inflammatory, anti-tumor and cytoprotective properties. Shown to significantly reduce the expression of several inflammatory mediators, including IL-6, IL-10, IL-12, TNFα, Mip1α and others. Reverses high fat diet-induced type 2 diabetes in C57BL/6 mice (3 mg/kg) and improves glucose homeostasis and insulin sensitivity. Down-regulates lipogenic gene expression in hepatocytes. Exhibits anti-proliferative activity in osteosarcoma cells (IC50 = 800, 150, 330, and 170 nM in HOB-c, KHOS, KHOSR2, and U2OS cells, respectively). Enhances the effectiveness of chemotherapeutic agents by inducing intrinsic mitochondrial-dependent apoptotic pathway. Reported to interact with multi cellular targets, namely, Nrf2-Keap1, IKK, JAK-STAT, PPARγ, ErbB2, PTEN, mTOR and Arp3 and covalently modify active site Cys residue via Michael addition.
          Catalogue Number505308
          Brand Family Calbiochem®
          SynonymsNSC 713200, Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate, Bardoxolone methyl, BARD, Nrf Activator V
          References
          ReferencesLiby, K.T. and Sporn, M.B., 2012. Pharmacol. Rev. 64, 972.
          Saha, P.K. et al. 2010. J. Biol. Chem. 285, 40581.
          Ryu, K., et al. 2010. BMC Cancer 10, 187.
          Liby, K.T., et al. 2007. Nat. Rev. Cancer 7, 357.
          Shishodia S., et al. 2006. Clin. Cancer Res. 12, 1828.
          Zou, W., et al. 2004. Cancer Res. 64, 7570.
          Kim, Y., et al. 2002. J. Biol. Chem. 277, 22320.
          Konopleva, M., et al. 2002. Blood 99, 326.
          Wang, Y., et al. 2000. Mol Endocrinol. 14, 1550.
          Product Information
          CAS number218600-53-4
          FormWhite solid
          Hill FormulaC₃₂H₄₃NO₄
          Chemical formulaC₃₂H₄₃NO₄
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          References

          Reference overview
          Liby, K.T. and Sporn, M.B., 2012. Pharmacol. Rev. 64, 972.
          Saha, P.K. et al. 2010. J. Biol. Chem. 285, 40581.
          Ryu, K., et al. 2010. BMC Cancer 10, 187.
          Liby, K.T., et al. 2007. Nat. Rev. Cancer 7, 357.
          Shishodia S., et al. 2006. Clin. Cancer Res. 12, 1828.
          Zou, W., et al. 2004. Cancer Res. 64, 7570.
          Kim, Y., et al. 2002. J. Biol. Chem. 277, 22320.
          Konopleva, M., et al. 2002. Blood 99, 326.
          Wang, Y., et al. 2000. Mol Endocrinol. 14, 1550.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision26-July-2013 JSW
          SynonymsNSC 713200, Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate, Bardoxolone methyl, BARD, Nrf Activator V
          DescriptionA cell-permeable, bioavailable synthetic oleanane triterpenoid compound with anti-inflammatory, anti-tumor and cytoprotective properties. Shown to significantly reduce the expression of several inflammatory mediators, including IL-6, IL-10, IL-12, TNFα, Mip1α and others. Reverses high fat diet-induced type 2 diabetes in C57BL/6 mice (3 mg/kg) and improves glucose homeostasis and insulin sensitivity. Down-regulates lipogenic gene expression in hepatocytes. Exhibits anti-proliferative activity in osteosarcoma cells (IC50 = 800, 150, 330, and 170 nM in HOB-c, KHOS, KHOSR2, and U2OS cells, respectively). Enhances the effectiveness of chemotherapeutic agents by inducing intrinsic mitochondrial-dependent apoptotic pathway. Reported to interact with multi cellular targets, namely, Nrf2-Keap1, IKK, JAK-STAT, PPARγ, ErbB2, PTEN, mTOR and Arp3 and covalently modify active site Cys residue via Michael addition.
          FormWhite solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number218600-53-4
          Chemical formulaC₃₂H₄₃NO₄
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (50 mg/ml). Use only fresh DMSO for reconstitution.
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesLiby, K.T. and Sporn, M.B., 2012. Pharmacol. Rev. 64, 972.
          Saha, P.K. et al. 2010. J. Biol. Chem. 285, 40581.
          Ryu, K., et al. 2010. BMC Cancer 10, 187.
          Liby, K.T., et al. 2007. Nat. Rev. Cancer 7, 357.
          Shishodia S., et al. 2006. Clin. Cancer Res. 12, 1828.
          Zou, W., et al. 2004. Cancer Res. 64, 7570.
          Kim, Y., et al. 2002. J. Biol. Chem. 277, 22320.
          Konopleva, M., et al. 2002. Blood 99, 326.
          Wang, Y., et al. 2000. Mol Endocrinol. 14, 1550.